The Training and Development Center at UAE's Ministry of Health recently organised a conference titled “2015 Emergency Cardiovascular Care Guidelines, International Instructor Update,” in partnership with the American Heart Ass
The fifth annual Case Based Approach to Controversies in Cardiovascular Disease Conference began today in Dubai, at Mohammed Bin Rashid Academic Medical Centre in Dubai Healthcare City.
Held under the patronage of HH Sheikh Hamdan
The advances in the prevention, diagnosis and treatment of cardiovascular disease will be the focus of a conference to take place in Dubai, UAE next month.
The fifth Annual Case Based Approach to Controversiers
Medeor 24x7 Hospital Abu Dhabi has organised free screenings for residents of the emirate to combat cardiovascular diseases, which is the number one killer in the UAE.
Accounting for one in four deaths in the U
The results of trial evaluating cardiovascular outcomes (Tecos) show that sitagliptin does not increase the risk of cardiovascular events in a diverse group of patients with type 2 diabetes at high cardiovascular risk, said a top professor.
A team of doctors from Dubai Health Authority (DHA) conducted a minimally invasive lifesaving cardiovascular procedure, for the first time in the UAE and the Middle-East region.
The procedure was performed on a 27-year-old Pakista
The current scenario of cardiovascular diseases prevalent in the Mena region were discussed at a convention in Colombo recently.
The second version of Tabuk Cardiovascular Convention (2nd TCC), which was organi
UAE-based Gulf & Word Traders (GTW), a leading medical equipment provider, has partnered with US-based Everist Genomics to offer a new non-invasive test that predicts risk for cardiovascular disease.
Everist Genomics, develope
Bahrain City Centre (BCC), the largest shopping mall in the Kingdom, is taking part in a global awareness campaign on the prevention of heart diseases amongst women.
Go Red for Women will be held within the mall premises on May 23
Cardiovascular diseases are the number one killer among Type 2 diabetes patients, according to a research by global healthcare major MSD.
MSD presented its latest diabetes research and development insights during the Congress of the Intern